5250-17-9 Usage
Description
(2E)-1-(5-chloro-2-hydroxyphenyl)-3-pyridin-2-ylprop-2-en-1-one is a chemical compound with a molecular formula of C14H10ClNO2. It is a derivative of the enone functional group and contains a chloro, hydroxy, and pyridinyl substituents. (2E)-1-(5-chloro-2-hydroxyphenyl)-3-pyridin-2-ylprop-2-en-1-one may have potential pharmacological or biological activities, as it contains structural elements commonly found in pharmaceuticals and natural products. It could be used in medicinal chemistry research or drug development due to its unique structural features and potential interactions with biological systems. Further studies are needed to fully understand the properties and applications of this compound.
Uses
Used in Pharmaceutical Industry:
(2E)-1-(5-chloro-2-hydroxyphenyl)-3-pyridin-2-ylprop-2-en-1-one is used as a potential pharmaceutical candidate for medicinal chemistry research and drug development. Its unique structural features and potential interactions with biological systems make it a promising compound for the development of new drugs.
Used in Natural Products Research:
(2E)-1-(5-chloro-2-hydroxyphenyl)-3-pyridin-2-ylprop-2-en-1-one is used as a compound with potential biological activities in the study of natural products. Its structural elements commonly found in pharmaceuticals and natural products make it a valuable compound for research in this field.
Check Digit Verification of cas no
The CAS Registry Mumber 5250-17-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,2,5 and 0 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5250-17:
(6*5)+(5*2)+(4*5)+(3*0)+(2*1)+(1*7)=69
69 % 10 = 9
So 5250-17-9 is a valid CAS Registry Number.
5250-17-9Relevant articles and documents
COMPOSITIONS FOR INHIBITING ANDROGEN DEPENDENT OR INDEPENDENT PROSTATE CANCER CELLS AND PHARMACEUTICAL FORMULATIONS OF PROSTATE CANCER CONTAINING THE SAME
-
Paragraph 0066, (2018/06/30)
PROBLEM TO BE SOLVED: To provide compositions for inhibiting androgen dependent or independent prostate cancer cells which are used for prostate cancer, inhibit activation of androgen receptors, are effective for inhibiting the proliferation of androgen dependent or independent prostate cancer, inhibit the action even if AR-V7 has expressed, and are effective also to anticancer drug resistant cell lines; and to provide pharmaceutical formulations of prostate cancer using the same. SOLUTION: A composition for inhibiting androgen dependent or independent prostate cancer cells comprises an α,β-saturated or unsaturated ketone derivative represented by the following chemical formula (1) or a pharmaceutically acceptable salt thereof. (X- represents a hydrocarbon aromatic ring group or an aromatic heterocyclic group, both or either of Y1- and Y2- are a hydrocarbon aromatic ring group or an aromatic heterocyclic group and the other is a hydrogen atom, Z= represents an atom or a functional group which forms or generates a ketone group, a thioketone group, an imino group, or an oxime group together with a bonding carbon atom, Y3- is a hydrogen atom, a perhalogeno hydrocarbon group or the like.) The pharmaceutical formulation of prostate cancer contains this composition. SELECTED DRAWING: None COPYRIGHT: (C)2018,JPOandINPIT
Dihydrothienocoumarines as analgesic agents without antiinflammatory activity
Xicluna,Ombetta,Navarro,et al.
, p. 523 - 528 (2007/10/04)
-